News on Clinical Horizons Research Incorporated from BioPortfolio.com http://www.BioPortfolio.com Consolidated Clinical Horizons Research Incorporated news from BioPortfolio.com Tue, 09 Feb 2010 21:43:50 GMT en Stock Hunter Is Hot!! Sign Up Today!! GETA,GOVX,NPWZ,VHGI,RDBO,SHMNhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032004&HITNO=0&MSIZE=59&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Clinical%20Horizons%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032004&THISHREF=http://c.moreover.com/click/here.pl%3fz2534464898%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032004&HITNO=0&MSIZE=59&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Clinical%20Horizons%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032004&THISHREF=http://c.moreover.com/click/here.pl%3fz2534464898%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Genta Initiates Phase 2 Study of Tesetaxel, the Leading Clinical-Stage Oral Taxane, in Patients with Advancedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031630&HITNO=1&MSIZE=59&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Clinical%20Horizons%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031630&THISHREF=http://c.moreover.com/click/here.pl%3fz2534281602%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031630&HITNO=1&MSIZE=59&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Clinical%20Horizons%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031630&THISHREF=http://c.moreover.com/click/here.pl%3fz2534281602%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Genta Initiates Phase 2 Study of Tesetaxel, the Leading Clinical-Stage Oral Taxane, in Patients with Advanced Melanomahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030110&HITNO=2&MSIZE=59&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Clinical%20Horizons%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030110&THISHREF=http://c.moreover.com/click/here.pl%3fz2533446623%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030110&HITNO=2&MSIZE=59&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Clinical%20Horizons%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030110&THISHREF=http://c.moreover.com/click/here.pl%3fz2533446623%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: Genta Initiates Phase 2 Study of Tesetaxel, the Leading Clinical-Stage Oral Taxane, in Patients with Advancedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029380&HITNO=3&MSIZE=59&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Clinical%20Horizons%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029380&THISHREF=http://c.moreover.com/click/here.pl%3fz2533116751%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029380&HITNO=3&MSIZE=59&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Clinical%20Horizons%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029380&THISHREF=http://c.moreover.com/click/here.pl%3fz2533116751%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Genta Initiates Phase 2 Study of Tesetaxel, the Leading Clinical-Stage Oral Taxane, in Patients with Advancedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031575&HITNO=4&MSIZE=59&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Clinical%20Horizons%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031575&THISHREF=http://c.moreover.com/click/here.pl%3fz2534268838%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031575&HITNO=4&MSIZE=59&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Clinical%20Horizons%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031575&THISHREF=http://c.moreover.com/click/here.pl%3fz2534268838%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Genta Initiates Phase 2 Study of Tesetaxel, the Leading Clinical-Stage Oral Taxane, in Patients with Advanced Melanomahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029666&HITNO=5&MSIZE=59&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Clinical%20Horizons%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029666&THISHREF=http://c.moreover.com/click/here.pl%3fz2533227500%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029666&HITNO=5&MSIZE=59&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Clinical%20Horizons%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029666&THISHREF=http://c.moreover.com/click/here.pl%3fz2533227500%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: Genta Initiates Phase 2 Study of Tesetaxel, the Leading Clinical-Stage Oral Taxane, in Patients with Advancedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029639&HITNO=6&MSIZE=59&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Clinical%20Horizons%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029639&THISHREF=http://c.moreover.com/click/here.pl%3fz2533217390%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029639&HITNO=6&MSIZE=59&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Clinical%20Horizons%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029639&THISHREF=http://c.moreover.com/click/here.pl%3fz2533217390%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: The Translational Genomics Research Institute Partners With Cambridge, UK, Firm In Cancer Researchhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4011287&HITNO=7&MSIZE=59&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Clinical%20Horizons%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4011287&THISHREF=http://c.moreover.com/click/here.pl%3fz2522864131%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4011287&HITNO=7&MSIZE=59&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Clinical%20Horizons%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4011287&THISHREF=http://c.moreover.com/click/here.pl%3fz2522864131%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: BiomedReports: News and FDA Updates for Seattle Genetics (Nasdaq:SGEN), Vertex (Nasdaq:VRTX), Vystar (OTC:VYST)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4014464&HITNO=8&MSIZE=59&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Clinical%20Horizons%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4014464&THISHREF=http://c.moreover.com/click/here.pl%3fz2524012356%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4014464&HITNO=8&MSIZE=59&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Clinical%20Horizons%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4014464&THISHREF=http://c.moreover.com/click/here.pl%3fz2524012356%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTradingMarkets: Phase Forward Reports Fourth Quarter and Full Year 2009 Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4017093&HITNO=9&MSIZE=59&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Clinical%20Horizons%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4017093&THISHREF=http://c.moreover.com/click/here.pl%3fz2525006202%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4017093&HITNO=9&MSIZE=59&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Clinical%20Horizons%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4017093&THISHREF=http://c.moreover.com/click/here.pl%3fz2525006202%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: Phase Forward Reports Fourth Quarter and Full Year 2009 Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4017045&HITNO=10&MSIZE=59&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Clinical%20Horizons%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4017045&THISHREF=http://c.moreover.com/click/here.pl%3fz2524989182%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4017045&HITNO=10&MSIZE=59&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Clinical%20Horizons%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4017045&THISHREF=http://c.moreover.com/click/here.pl%3fz2524989182%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsBlaze: Phase Forward Reports Fourth Quarter and Full Year 2009 Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4017005&HITNO=11&MSIZE=59&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Clinical%20Horizons%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4017005&THISHREF=http://c.moreover.com/click/here.pl%3fz2524973100%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4017005&HITNO=11&MSIZE=59&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Clinical%20Horizons%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4017005&THISHREF=http://c.moreover.com/click/here.pl%3fz2524973100%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBusiness Wire via Yahoo!: Phase Forward Reports Fourth Quarter and Full Year 2009 Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4016988&HITNO=12&MSIZE=59&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Clinical%20Horizons%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4016988&THISHREF=http://c.moreover.com/click/here.pl%3fz2524968266%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4016988&HITNO=12&MSIZE=59&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Clinical%20Horizons%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4016988&THISHREF=http://c.moreover.com/click/here.pl%3fz2524968266%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSys-Con Media: Phase Forward Reports Fourth Quarter and Full Year 2009 Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4016985&HITNO=13&MSIZE=59&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Clinical%20Horizons%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4016985&THISHREF=http://c.moreover.com/click/here.pl%3fz2524967470%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4016985&HITNO=13&MSIZE=59&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Clinical%20Horizons%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4016985&THISHREF=http://c.moreover.com/click/here.pl%3fz2524967470%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYour Story: TGen, Horizon Discovery partner in development of novel cancer cell-lineshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4003763&HITNO=14&MSIZE=59&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Clinical%20Horizons%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4003763&THISHREF=http://c.moreover.com/click/here.pl%3fz2519665428%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4003763&HITNO=14&MSIZE=59&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Clinical%20Horizons%20Research%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4003763&THISHREF=http://c.moreover.com/click/here.pl%3fz2519665428%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: